Legislation Roundup: Pharma Data Protection, and Beijing and Guangdong Data Transfers

Innovative drugs are accorded a six-year data protection period. Beijing and Guangdong add more details to their data transfer negative lists.

By Susan Mok

Healthcare

National Medical Products Administration, Implementing Measures for the Protection of Pharmaceutical Trial Data

A Subscription is Required to Access this Content

Subscribe to China Law & Practice today for:

✓ A database of 3000+ essential documents, including key PRC laws translated into English
✓ Newsletters with business-critical and sector-specific updates
✓ Premium mobile access with timely analysis on China's fast-changing market

Already a Subscriber? Log In. Sign In Now

Questions? Contact us at [email protected] | 1-855-808-4530 (Americas) | 44(0) 800 098 386009 (UK & Europe)